Report error Found 75 Enz. Inhib. hit(s) with all data for entry = 12572
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetE3 ubiquitin-protein ligase XIAP [238-358](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetBaculoviral IAP repeat-containing protein 3 [236-342](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
TargetE3 ubiquitin-protein ligase XIAP [238-358](Human)
Nanjing China-Australia Institute of Translational Medicine
US Patent
Nanjing China-Australia Institute of Translational Medicine
US Patent
